Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
RUNX1 mutation in a patient with myelodysplastic...
Journal article

RUNX1 mutation in a patient with myelodysplastic syndrome and decreased erythrocyte expression of blood group A antigen

Abstract

BACKGROUND: Loss of blood group ABO antigens on red blood cells (RBCs) is well known in patients with leukemias, and such decreased ABO expression has been reported to be strongly associated with hypermethylation of the ABO promoter. We investigated the underlying mechanism responsible for A-antigen reduction on RBCs in a patient with myelodysplastic syndrome. STUDY DESIGN AND METHODS: Genetic analysis of ABO was performed by PCR and sequencing …

Authors

Hayakawa A; Sano R; Takahashi Y; Kubo R; Harada M; Omata M; Yokohama A; Handa H; Tsukada J; Takeshita H

Journal

Transfusion, Vol. 60, No. 1, pp. 184–196

Publisher

Wiley

Publication Date

1 2020

DOI

10.1111/trf.15628

ISSN

0041-1132